Skip to main content
Press Release

GE Healthcare Unveils Breakthrough Low-Dose Imaging Technology in Canada

July 25, 2011

GE's latest CT image reconstruction technology, Veo, helps physicians accurately diagnose through high quality images at significantly lower dose

First wave of Canadian clinical and academic installations underway

TORONTO, ONTARIO -- July 25, 2011 -- GE Healthcare announced the introduction of a breakthrough Computed Tomography (CT) image reconstruction technology, called Veo,*^ in Canada. The industry's first Model-based Iterative Reconstruction (MBIR) technique, Veo is designed to help physicians deliver accurate diagnoses by enabling high CT image quality at significantly lower dose.+

When compared to previous reconstruction methods, Veo's capabilities "change the rules" of CT imaging by applying revolutionary new modeling techniques to potentially deliver lower noise, increased resolution, improved low contrast detectability and fewer artifacts. Already available in Europe and much of Asia, Veo is now available in Canada on the GE Discovery* CT750 HD system. It is not yet available for sale in the United States.

Responding to radiologists' demand for maximum CT image clarity and optimized low dose for their patients, Veo represents a powerful new tool that can help physicians more clearly visualize anatomy in order to deliver informed, accurate and confident diagnoses.

"The recent release of Veo in Canada offers radiologists the opportunity to expand on the gains made by Adaptive Statistical Iterative Reconstruction (ASiR)," said Dr. Jonathon Leipsic, Head of Radiology, Providence Health, St. Paul's Hospital in Vancouver. "Veo has the potential to push radiation dose lower across organ systems while reducing image noise and improving spatial resolution -- which would allow for more robust imaging of small structures and more confident assessment of heavily calcified arteries, an ongoing challenge in CT angiography."

After decades of CT image reconstruction using filtered back projection and more recent advances in statistical raw data-based iterative reconstruction, such as GE's powerful ASiR technology, Veo takes the next step by modeling the system itself and more complex data to help create outstanding clinical image quality at even lower dose levels.

"Given our proven history of CT imaging innovations, GE is proud to bring to market yet another innovative, patient-friendly technology in Canada," said Peter Robertson, Vice President and General Manager of GE Healthcare Canada. "Veo can help clinicians and radiologists improve patient care by offering higher image quality and dramatically lower dose levels."

GE Healthcare is helping coordinate a multi-center study to investigate the improvements Veo may offer -- including substantially lower dose levels -- across a range of applications.

Developed in partnership with leading academic researchers and experts from GE's Global Research Center, Veo is available with the Discovery CT750 HD, a 'healthymagination-certified' product, meaning that it helps enable better healthcare for more people.

* Trademark of General Electric Company
^Veo is 510(k) Pending and not available in the US
+ In clinical practice, the use of Veo may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.

Sarah Triantafillou
[email protected]

business unit